Cargando…

Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer

BACKGROUND: Many oncological drugs that are being used in the adjuvant setting were first submitted for reimbursement in the metastatic stage, with differences in incremental cost-effectiveness ratios (ICERs) in both settings having potential implications for reimbursement and pricing. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dvortsin, Evgeni, Gout-Zwart, Judith, Eijssen, Ernst-Lodewijk Marie, van Brussel, Jan, Postma, Maarten J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723090/ https://www.ncbi.nlm.nih.gov/pubmed/26800029 http://dx.doi.org/10.1371/journal.pone.0146551

Ejemplares similares

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review
por: van Schoonhoven, Alexander V., et al.
Publicado: (2019)

Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost
por: Zeevat, Florian, et al.
Publicado: (2021)

A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy
por: Berm, Elizabeth J. J., et al.
Publicado: (2016)

Modelling the Cost-Effectiveness of Implementing a Dietary Intervention in Renal Transplant Recipients
por: Coerts, Friso B., et al.
Publicado: (2021)

Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
por: Gout-Zwart, Judith J., et al.
Publicado: (2019)

Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations
por: Gout-Zwart, Judith J., et al.
Publicado: (2018)

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands
por: Stevanović, J., et al.
Publicado: (2016)

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
por: de Jong, Lisa A., et al.
Publicado: (2018)

Cost analysis and cost-effectiveness of open versus laparoscopic versus robot-assisted versus transanal total mesorectal excision in patients with rectal cancer: a protocol for a systematic review
por: Geitenbeek, Ritchie T J, et al.
Publicado: (2022)

Burden of early, advanced and metastatic breast cancer in The Netherlands
por: Vondeling, G. T., et al.
Publicado: (2018)

Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism
por: de Jong, Lisa A, et al.
Publicado: (2020)

Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study
por: Cong, Ze, et al.
Publicado: (2022)

Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy
por: Schwander, Bjoern, et al.
Publicado: (2012)

Early versus late initiation of GH replacement in adult-onset hypopituitarism
por: Postma, Mark R, et al.
Publicado: (2020)

Comorbidities and the Risk of Late-Stage Prostate Cancer
por: Fleming, Steven T., et al.
Publicado: (2006)

Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia
por: Suwantika, Auliya A, et al.
Publicado: (2013)

Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study
por: van Aalst, Robertus, et al.
Publicado: (2021)

Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands
por: Hubben, Gijs AA, et al.
Publicado: (2007)

EBUS-TBNA versus mediastinoscopy for mediastinal staging of lung cancer: a cost-minimization analysis
por: Motta, João Pedro Steinhauser, et al.
Publicado: (2022)

Genomic predictors for treatment of late stage prostate cancer
por: Shevrin, Daniel H
Publicado: (2016)

Geographic Variation in Late-Stage Cervical Cancer Diagnosis
por: Sokale, Itunu O., et al.
Publicado: (2023)

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?
por: Standaert, Baudouin, et al.
Publicado: (2014)

Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis
por: Setiawan, Didik, et al.
Publicado: (2020)

Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
por: Al-Ziftawi, Nour Hisham, et al.
Publicado: (2022)

803 Direct Costs and Duration of Hospitalization of Patients Hospitalized with Community Acquired Pneumonia: a Nationwide Retrospective Claims Database Analysis
por: Rozenbaum, Mark, et al.
Publicado: (2014)

Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer
por: Gout, Stéphanie, et al.
Publicado: (2008)

LIM only 4 is overexpressed in late stage pancreas cancer
por: Yu, Jun, et al.
Publicado: (2008)

Increased platelet reactivity in patients with late-stage metastatic cancer
por: Cooke, Niamh M, et al.
Publicado: (2013)

Anxiety level of early- and late-stage prostate cancer patients
por: Johanes, Charles, et al.
Publicado: (2013)

Disparate survival of late-stage male oropharyngeal cancer in Appalachia
por: Papenberg, Brenen W., et al.
Publicado: (2020)

Factors associated with late-stage presentation of cervical cancer in Ghana
por: Appiah-Kubi, Adu, et al.
Publicado: (2022)

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
por: Al Khayat, Mohamed N. M. T., et al.
Publicado: (2022)

Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana
por: Friebel-Klingner, Tara M., et al.
Publicado: (2021)

Volumetric modulated arc therapy versus tomotherapy for late T-stage nasopharyngeal carcinoma
por: Chen, Qian, et al.
Publicado: (2022)

Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2016)

Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review
por: Fitria, Najmiatul, et al.
Publicado: (2018)

Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison
por: Hakimi, Zalmai, et al.
Publicado: (2020)

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
por: Dolk, Christiaan, et al.
Publicado: (2016)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

Economic analysis of open versus laparoscopic versus robot-assisted versus transanal total mesorectal excision in rectal cancer patients: A systematic review
por: Geitenbeek, Ritchie T. J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hprrbojc3be7g5gb8n4pmga8co